Are azole fungicides a teratogenic risk for human conceptus?

Toxicology Letters
E Giavini, E Menegola

Abstract

Azole fungicides are widely used in agriculture and in human mycosis. Their antifungal activity is based on their ability to inhibit CYP51, a key enzyme in the formation of fungal wall. Several azole fungicides tested in laboratory animals have been found to possess a common teratogenic potential to induce facial, axial skeleton, and limb defects. The mechanism of the teratogenic effect has been hypothesized to be related to the capability of these substances to alter embryonic retinoic acid catabolism. Although a number of human epidemiological studies were unable to demonstrate a definite relationship between azole exposure during pregnancy and birth defects, some case reports indicate a possible teratogenic effect of high doses of azoles in humans. Because of their common mechanism of action, azole fungicides should be regarded with caution for use in pregnant women.

References

Feb 1, 1978·Biological Reviews of the Cambridge Philosophical Society·D A New
Jan 1, 1992·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·G Morriss-Kay
Dec 1, 1992·The Pediatric Infectious Disease Journal·B E LeeA R Murthy
Apr 1, 1990·Trends in Neurosciences·D Summerbell, M Maden
Apr 1, 1991·Clinical Pharmacology and Therapeutics·R A BlumJ J Schentag
Jan 1, 1985·Current Topics in Medical Mycology·H Vanden Bossche
Oct 1, 1983·Toxicology Letters·M L Giknis, I Damjanov
Mar 1, 1995·Bulletin of Environmental Contamination and Toxicology·K Machera
Feb 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J PursleyJ A Bartley
Dec 1, 1996·American Journal of Obstetrics and Gynecology·P MastroiacovoD Fusco
Apr 9, 1998·British Journal of Obstetrics and Gynaecology·A E Czeizel, M Rockenbauer
Nov 25, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C T KingS W Chapman
Feb 25, 1999·Pharmacotherapy·S S Jick
Jun 4, 1999·Mechanisms of Development·K de RoosP T van der Saag
Jul 27, 1999·British Journal of Clinical Pharmacology·H T SorensenA E Czeizel
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Mar 16, 2000·In Vitro Cellular & Developmental Biology. Animal·E MenegolaE Giavini
Jul 14, 2000·Physiological Reviews·S A RossL M De Luca
Aug 22, 2000·European Journal of Clinical Pharmacology·T KantolaP J Neuvonen
Sep 19, 2000·American Journal of Obstetrics and Gynecology·B Bar-OzG Koren
Aug 8, 2001·Reproductive Toxicology·E MenegolaE Giavini
May 15, 2003·Archives of Biochemistry and Biophysics·D ChoudharyI Stoilov
May 22, 2003·Journal of Pediatric Hematology/oncology·Kelly L VanierDonna L Johnston
May 29, 2003·Birth Defects Research. Part A, Clinical and Molecular Teratology·Elena MenegolaErminio Giavini
Jul 18, 2003·Clinical Therapeutics·LilyAnn JeuHoratio B Fung
Nov 5, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Andrew E CzeizelPeter Vargha
Mar 11, 2004·Congenital Anomalies·Andrew Endre CzeizelErzsébet Puhó
Jul 21, 2004·American Journal of Medical Genetics. Part a·Masanori AdachiAkira Oka
Mar 2, 2005·Congenital Anomalies·Zoltán KazyAndrew E Czeizel
Apr 12, 2005·Drugs of Today·Pramodini Kale, Leonard B Johnson
Apr 19, 2005·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Elena MenegolaErminio Giavini
May 20, 2005·Pediatric Research·Gian M Tiboni, Franca Giampietro
May 26, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·E MenegolaE Giavini
Sep 15, 2005·Reproductive Toxicology·Elena MenegolaErminio Giavini

❮ Previous
Next ❯

Citations

Mar 19, 2014·European Journal of Medicinal Chemistry·Kishor S JainEvans C Coutinho
Mar 13, 2014·Journal of Exposure Science & Environmental Epidemiology·Silvia FustinoniAngelo Moretto
May 28, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Harm J HeusinkveldRemco H S Westerink
Jun 6, 2012·Reproductive Toxicology·Joshua F RobinsonAldert H Piersma
Nov 22, 2011·European Journal of Medicinal Chemistry·Niina TaniRisto O Juvonen
Jan 22, 2011·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Francesca Di RenzoElena Menegola
Jul 15, 2015·Toxicology·Nathália Orlandini CostaDaniela Cristina Ceccatto Gerardin
Nov 28, 2013·Critical Reviews in Toxicology·Janice E ChambersGlen Van Der Kraak
Dec 10, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hequn LiBennard van Ravenzwaay
Jul 19, 2016·Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes·Monika DrážovskáViera Schwarzbacherová
Sep 26, 2014·Chemical Research in Toxicology·R MercadanteS Fustinoni
Apr 4, 2017·Environmental Toxicology and Chemistry·Hung T VuVincent J Pettigrove
Apr 19, 2017·International Journal of Molecular Sciences·Maria Zoupa, Kyriaki Machera
Apr 11, 2019·Polymers·Jiangqi XuXing Wang
May 22, 2020·BMJ : British Medical Journal·Yanmin ZhuKrista F Huybrechts
Oct 31, 2020·Birth Defects Research·Michael A GarlandChengji J Zhou
Feb 13, 2021·Ecotoxicology and Environmental Safety·Francielen Barroso AragãoSilvia Tamie Matsumoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.